In vitro stimulated lymphocytes as a source of human hybridomas
- 1 January 1984
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 14 (1) , 23-27
- https://doi.org/10.1002/eji.1830140105
Abstract
Stimulation of peripheral blood lymphocyte (PBL) cultures from tetanus toxoid (TT)-immunized donor with Epstein-Barr virus (EBV) yielded cells with much higher frequencies of hybrid formation (36 × 10−7) compared to unstimulated PBL or cells cultured with pokeweed mitogen or TT antigen. The proportion of hybridomas (approximately 1%) producing anti-TT antibody was similar in EBV- and TT-stimulated cultures. A marked increase in immunoglobulin secretion was observed after hybridization and preselection of EBV subcultures for high anti-TT production prior to fusion resulted in a fivefold increase in TT-specific hybridomas (pin vitro, with EBV, prior to fusion, should yield an increasing spectrum of human monoclonal antibodies for diagnostic, therapeutic or basic studies.This publication has 15 references indexed in Scilit:
- The production of monoclonal antibodies from human lymphocytesImmunology Today, 1983
- Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas.The Journal of Experimental Medicine, 1982
- Production of autoantibodies by human-human hybridomas.Journal of Clinical Investigation, 1982
- HUMAN HYBRIDOMAS FROM MALIGNANT GLIOMASThe Lancet, 1982
- Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual.The Journal of Experimental Medicine, 1982
- Production of human hybridomas secreting antibodies to measles virusNature, 1980
- [27] KaryotypingPublished by Elsevier ,1979
- Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitroNature, 1977
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell linesInternational Journal of Cancer, 1973